SLC39A1 and glioma: In this study, K-M survival analysis, univariate Cox analysis, multivariate Cox analysis, ROC curve analysis, and other methods are employed, using the TCGA, GEO and CCGA databases, to show that SLC39A1 independently indicated poor prognosis in patients with gliomas.